Table of Contents
Chapter one: Executive Summary
- Overview
- Scope and Methodology
- Contraception Management
- Contraceptive Use Worldwide
- Contraceptive Use in the U.S.
- Types of Contraception
- New Contraceptive Products
- Hormonal Contraception Products Market and Forecast
- Infertility Management
- Treating Infertility
- Cost of Treating Infertility
- Infertility Pharmaceutical Market
- ART Cycles of Treatment Performed in the United States
- U.S. ART Market Forecast
Chapter two: Introduction to Contraception and Fertility Management
- Overview
- Contraception Management
- Contraceptive Use Worldwide
- Oral Contraceptive Use Worldwide
- Types of Contraception
- Sterilization
- Oral Contraceptives
- Transdermal Patch
- Condoms
- Injectable Contraceptives
- Diaphragm
- Implant
- Spermicides
- Intrauterine Devices
- Sponge
- Cervical Cap
- Withdrawal
- Periodic Abstinence
- Emergency Contraception
- Infertility Management
- Infertility Evaluation
- Female Examination
- Male Examination
- Fertility Diagnostics
- Fertility Treatments
- Pharmaceutical Therapy
- Surgical Procedures
- Artificial Insemination
- Assisted Reproductive Technologies
Chapter three: Contraception
- A Brief History of Contraception
- Worldwide Contraception Use
- Contraceptive Use in the United States
- Types of Contraception - Overview
- Surgical Sterilization
- Female Sterilization
- Male Sterilization
- Hormonal Contraceptives
- Oral Contraceptives
- Types of Oral Contraceptives
- Contraceptive Implants
- Injected Contraceptives
- Intrauterine Hormone-Releasing Devices
- Transdermal Contraceptive
- Vaginal Ring
- Emergency Contraceptives
- Prescription Contraceptive Devices
- Cervical Devices
- Intrauterine Devices
- Contraceptive Research and Development
- NICHD Program: Reproductive Health in the 21st Century
- Contraceptive Clinical Trials Network (CCTN)
- Contraceptives in R&D
- Chemical Barriers
- Mechanical Barrier Methods
- Biodegradable Implants
- Male Contraceptives
- Hormonal Contraception Product Market
- New Contraceptive Products
- Cost to User of Various Contraceptive Products/Procedures
- Hormonal Contraception Products Market and Forecast
- Hormonal Contraception Market Share
- Market Analysis
- Oral and Injected Contraceptives
- Contraceptive Patch Quickly Gaining Market Share
- Hormonal Contraceptive Devices
- Contraceptive Implants
chapter four: Infertility Management
- A Brief History of Infertility Management
- Overview of Infertility Management
- SART/ASRM Clinical Guidelines
- Infertility Prevalence in U.S.
- Female Reproductive System
- Male Reproductive System
- Infertility Evaluation
- Female Endocrine System Examination
- Pelvic Factor Investigation
- Male Factor Infertility
- Treating Infertility
- Pharmaceutical Treatments
- Surgical Procedures
- Artificial Insemination
- Assisted Reproductive Techniques (ART)
- Infertility Pharmaceutical Treatments In R&D
- New Research May Lead to an Oral FSH Option
- Affect of Oral Contraceptives on IVF Treatment
- Current R&D Programs
- Reproductive Science in the 21st Century
- Cost of Treating Infertility
- The Infertility Pharmaceutical Market
- World Infertility Pharmaceutical Market Forcast
- Leading Products and Manufacturers
- Market Analysis
- U.S. ART Treatment Market
- ART Cycles of Treatment Performed in the United States
- U.S. ART Market Forecast
- IVF--Leading ART Procedure
chapter Five: Issues and Trends in Reproductive Medicine
- Contraception
- Overview of Major Issues and Trends
- Insurance Coverage for Contraceptives
- OTC Emergency Contraception
- Infertility Management
- Overview of Major Issues and Trends
- Prenatal Diagnostic Techniques
- Growing Trend of Multiple Births
- Insurance Coverage for the Evaluation and Treatment Infertility
Chapter six: Company Profiles
- Barr Laboratories
- History and Lines of Business
- Business Strategy
- Contraception Products
- Financial Information
- Berlex, Inc.
- History and Lines of Business
- Contraceptive Products
- Financial Information
- Conceptus, Inc.
- History and Lines of Business
- Business Strategy
- Contraceptive Device
- Financial Information
- Ferring Pharmaceuticals AS
- History and Lines of Business
- Business Strategy
- Fertility Products
- Financial Information
- Organon International
- History and Lines of Business
- Strategic Alliance
- Contraception Products
- Fertility Products
- Financial Information
- Ortho-McNeil Pharmaceutical, Inc.
- History and Lines of Business
- Contraception Products
- Financial Information
- Serono, Inc.
- History and Lines of Business
- Strategic Research Partnerships
- Infertility Products
- Financial Information
- Watson Pharmaceuticals, Inc.
- History and Lines of Business
- Contraception Products
- Finanacial Information
- Wyeth
- History and Lines of Business
- Contraception Products
- Financial Information
- Appendix A: Company Directory
- Appendix B: Hormonal Contraceptives Available in the United States, 2005
- Appendix C: Selected Reproductive Clinics in the United States, by State
- Appendix D: Institutes, Professional Organizations and Societies in Reproductive Medicine
List of Exhibits
Chapter one: Executive Summary
- Table 1-1: Selected New Hormonal Contraceptive Products Introduced to the U.S. Market 2000-2004
- Table 1-2: User Cost of Selected Contraceptive Products and Procedure in the United States, 2004
- Table 1-3: The World Market for Hormonal Contraception Products 2000-2005
- Figure 1-1: Hormonal Contraception Products World Market Share by Type 2004
- Table 1-4: Selected Infertility Pharmaceutical Treatments Currently Available in the United
States
- Table 1-5: Infertility Diagnostic and Treatment Costs in the United States by Procedure Type
- Table 1-6: World Infertility Pharmaceutical Market, 2000-2005
- Table 1-7: Number of ART Cycles of Treatment Performed in the United States 2000-2008
- Table 1-8: United States Market for ART (in Millions of U.S. Dollars) 2000-2005
Chapter two: Introduction to Contraception and Fertility Management
- Table 2-1: Estimates of Contraceptive Use Among Married Women Ages 15-49 Worldwide, by Type and
Region, 2000
- Table 2-2: Estimated Ever-Use of Oral Contraceptives and Any Contraceptive Among Married and
Among Sexually Active Unmarried Women Ages 15-49 by Region, 2000
Chapter three: Contraception
- Table 3-1: Timeline of the Development of Modern Contraceptives
- Figure 3-1: Contraceptive Use Among Couples Worldwide Percentage by Type, 2000
- Figure 3-2: Contraceptive Use in Developing Countries by Percentage Increase, 1960-2000
- Table 3-2: Percentage of Contraceptive Use Among Women of Child-Bearing Age, by Method of
Contraception and Age Group in the United States
- Table 3-3: Selected Monophasic Contraceptives Currently Available in the United States
- Table 3-4: Selected Biphasic Contraceptives Available in the United States
- Table 3-5: Selected Triphasic Contraceptives Available in the United States
- Table 3-6: Selected Progesterone-only Contraceptives Available in the United States
- Table 3-7: Dedicated Emergency Contraceptices and Oral Contraceptives
- Used for Emergency Contraceptives
- Table 3-8: Selected Prescription Contraceptive Devices
- Figure 3-3: Number of New Molecular Entities Approved, 1998-2003
- Figure 3-4: Cummulative Number of Patients by Disease/Treatment 1976 to 2004
- Table 3-9: Contraceptives in Research and Development Innovator, Product, Description, and
Research Status
- Table 3-10: Selected New Hormonal Contraceptive Products Introduced to the U.S. Market,
2000-2004
- Table 3-11: User Cost of Selected Contraceptive Products/Procedure in the United States 2004
- Table 3-12: The World Market for Hormonal Contraception Products 2000-2008
- Figure 3-5: Hormonal Contraception Products, World Market Share by Type, 2004
- Figure 3-6: Hormonal Contraception Products, U.S. Market Share by Type 2004
- Table 3-13: World Hormonal Contraceptive Market Share and Revenues by Competitor 2004
- Figure 3-7: World Hormonal Contraceptic Competitive Market Share 2004
chapter four: Infertility Management
- Figure 4-1: Phases of the Female Reproductive Cycle
- Table 4-1: Infertility Standard Screening Tests
- Table 4-2: Common Infertility Diagnostic Tests
- Table 4-3: Selected Infertility Pharmaceutical Treatments Currently
- Available in the United States
- Table 4-4: Summary of Results from the Assisted Reproductive Technology Surveillance Report in
United States, 2001
- Figure 4-2: Four-Stage In Vitro Fertilization Process
- Table 4-5: Major Infertility Pharmaceutical Competitors Pipelines, 2005 Manufacturer, Product,
Description, Development Phase
- Table 4-6: Infertility Diagnostic and Treatment Costs in the United States
- Table 4-7: World Infertility Pharmaceutical Market 2000-2008
- Table 4-8: Most Frequently Prescribed Infertility Pharmaceutical
- Brands in the United States by Category
- Table 4-9: World Fertility Pharmaceutical Market Market Share and Revenues by Competitor 2004
- Figure 4-3: Infertility Pharmaceutical Competitive Market Share 2004
- Table 4-10: Number of ART Cycles of Treatment Performed in the United States 2000-2008
- Table 4-11: Number of Live Births and Babies Delivered through Assisted Reproductive
Technologies in the United States, 1997-2002
- Table 4-12: U.S. ART Market by Cycle Type (With vs Without Donor Eggs) 2000-2008
- Figure 4-4: Specific Types of ART Performed in 2002
- Figure 4-5: Live Births per Retrieval for Different Types of ART Procedures Using Fresh Nondonor
Eggs or Embryos, 2002
- Figure 4-6: Expanding Use of Intracytoplasmic Sperm Injection (ICSI)
- Figure 4-7: IVF with ICSI in Comparison to IVF without ICSI, by Womans Age, 2002
chapter Five: Issues and Trends in Reproductive Medicine
- Table 5-1: State Mandated Benefits: Contraceptives, 2003 Table 5-2: States that Either Mandate
to Offer or Mandate to Cover Infertility Diagnosis and Treatment, 2003
Chapter six: Company Profiles
- Table 6-1: Barr Laboratories Current Generic Oral Contraceptive Product Portfolio
Appendix C: Selected Reproductive Clinics in the United States, by State
- Figure C-1: Location of ART Clinics in the United States and Puerto Rico
| 
View Cart
